Beiersdorf

DZ BANK reduces the fair value for Beiersdorf from €77 to €74 but confirms the "hold" rating. Analyst Thomas Maul sees the recovery of the Nivea brand as uncertain and expects its weakness to temporarily overshadow the strong dermatology brands. Higher marketing, a stronger focus on local needs and cheaper new products should bring Nivea back on track. The share traded in the afternoon at around €75.76 and is down about 18.0 percent year-to-date. » More on finanzen.net

Deutsche Bank Research confirms the rating for Beiersdorf at "Sell" and names a price target of €70. Analyst Tom Sykes expects a comparable revenue decline of 2.4% in 2026 and a margin of 11.9%, below the prior year's level. The Beiersdorf share traded slightly lower and shows roughly 10% downside risk relative to the price target. » More on finanzen.net

Jefferies lowered its price target for Beiersdorf from €76 to €74 and maintained the hold rating. Analyst David Hayes cites the Nivea brand, continued inventory reductions in Western Europe, tensions with retailers and frozen assets in Russia as key risks. The dermatology segment, however, continues to perform positively. » More on finanzen.net